| 000 | 01036 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513183551.0 | ||
| 264 | 0 | _c19990604 | |
| 008 | 199906s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCalhoun, E A | |
| 245 | 0 | 0 |
_aPharmacoeconomics of amifostine in ovarian cancer. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cApr 1999 |
||
| 300 |
_a102-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmifostine _xeconomics |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aCanada |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aCytoprotection |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Economic |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xeconomics |
| 650 | 0 | 4 |
_aProtective Agents _xeconomics |
| 650 | 0 | 4 | _aQuality-Adjusted Life Years |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aBennett, C L | |
| 773 | 0 |
_tSeminars in oncology _gvol. 26 _gno. 2 Suppl 7 _gp. 102-7 |
|
| 999 |
_c10306937 _d10306937 |
||